• Latest Posts
In Depth 1 Feb 2023

How can cancer care be improved?

ImaginAb launches trial to study neoadjuvant immunotherapy

ImaginAb launching clinical trial for renal cancer and malignant melanoma

Parthenon and ImaginAb enter into license and supply agreement for anti-cancer therapies

First patient dosed in trial to assess predictive performance of immuno-oncology therapy